Non-medicated Valchlor Demonstration
NDC Package 66215-001-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Non-medicated Valchlor Demonstration is a . Marketed by Actelion Pharmaceuticals Us, Inc., this product is identified by NDC 66215-001 and is authorized under FDA application NDA202317.

Identification & Billing

NDC Package Code
66215-001-05
Package Description
1 TUBE in 1 CARTON / 5 g in 1 TUBE
Product Code
66215-001
11-Digit Billing Format
66215000105

Clinical Specifications

Proprietary Name
Non-medicated Valchlor Demonstration
Dosage Form
-

Regulatory & Marketing

Labeler Name
Actelion Pharmaceuticals Us, Inc.
FDA Application #
NDA202317
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-13-2016
End Marketing Date
12-05-2019
Listing Expiration
12-05-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66215-001-05 identifies a specific commercial package of 1 tube in 1 carton / 5 g in 1 tube of Non-medicated Valchlor Demonstration, labeled by Actelion Pharmaceuticals Us, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actelion Pharmaceuticals Us, Inc. on January 13, 2016. The current certification is valid through December 05, 2019.

How is this Actelion Pharmaceuticals Us, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66215000105. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66215-001-05
11-Digit CMS (5-4-2)
66215-0001-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.